Literature DB >> 29769382

Personalized Symptom Goals and Patient Global Impression on Clinical Changes in Advanced Cancer Patients.

Sebastiano Mercadante1, Claudio Adile2, Gaetano Lanzetta3,4, Kyriaki Mystakidou5, Marco Maltoni6, Luiz Guilherme Soares7, Stefano De Santis8, Patrizia Ferrera2, Marco Valenti9, Marta Rosati6, Romina Rossi6, Andrea Cortegiani10, Francesco Masedu9, Franco Marinangeli11, Federica Aielli9.   

Abstract

BACKGROUND: The aim of this study was to assess the patients' global impression (PGI) after symptom management, as well as the achievement of personalized symptom goals (PSG). The secondary outcome was to assess related factors. SUBJECTS, MATERIALS, AND METHODS: Advanced cancer patients admitted to palliative care units rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission and then after 1 week. For each symptom, patient-reported PGI and PSG, as well as the rate of PSG response, were evaluated.
RESULTS: Eight hundred seventy-six patients were taken into consideration for this study. A mean of 1.71-2.16 points was necessary to perceive a bit better improvement of symptom intensity. Most patients had a PSG of ≤3. A statistically significant number of patients achieved their PSG after starting palliative care. Patients with high intensity of ESAS items at admission achieved a more favorable PGI response. In the multivariate analysis, symptom intensity and PSG were the most frequent factors independently associated to a best PGI, whereas high levels of Karnofsky had a lower odd ratio.
CONCLUSION: PSG and PGI seem to be relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. IMPLICATIONS FOR PRACTICE: Personalized symptom goals and global impression of change are relevant for patients' assessment and decision-making process, translating in terms of therapeutic intervention. Some factors may be implicated in determining the individual target and clinical response. © AlphaMed Press 2018.

Entities:  

Keywords:  Advanced cancer; Global impression of change; Palliative care; Personalized symptom goal; Symptom assessment

Mesh:

Year:  2018        PMID: 29769382      PMCID: PMC6369942          DOI: 10.1634/theoncologist.2017-0668

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  16 in total

Review 1.  Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.

Authors:  Geoffrey R Norman; Jeff A Sloan; Kathleen W Wyrwich
Journal:  Med Care       Date:  2003-05       Impact factor: 2.983

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  Minimal clinically important differences in the edmonton symptom assessment system: the anchor is key.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2013-03       Impact factor: 3.612

4.  The clinical importance of changes in the 0 to 10 numeric rating scale for worst, least, and average pain intensity: analyses of data from clinical trials of duloxetine in pain disorders.

Authors:  John T Farrar; Yili L Pritchett; Michael Robinson; Apurva Prakash; Amy Chappell
Journal:  J Pain       Date:  2009-08-08       Impact factor: 5.820

5.  Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study.

Authors:  David Hui; Omar Shamieh; Carlos Eduardo Paiva; Pedro Emilio Perez-Cruz; Jung Hye Kwon; Mary Ann Muckaden; Minjeong Park; Sriram Yennu; Jung Hun Kang; Eduardo Bruera
Journal:  Cancer       Date:  2015-06-08       Impact factor: 6.860

6.  Validation of the Edmonton Symptom Assessment Scale.

Authors:  V T Chang; S S Hwang; M Feuerman
Journal:  Cancer       Date:  2000-05-01       Impact factor: 6.860

7.  Personalized symptom goals and response in patients with advanced cancer.

Authors:  David Hui; Minjeong Park; Omar Shamieh; Carlos Eduardo Paiva; Pedro Emilio Perez-Cruz; Mary Ann Muckaden; Eduardo Bruera
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

8.  Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use.

Authors:  Henrique A Parsons; Marvin Omar Delgado-Guay; Badi El Osta; Ray Chacko; Valerie Poulter; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

9.  Responsiveness and minimal clinically important difference for pain and disability instruments in low back pain patients.

Authors:  Henrik H Lauridsen; Jan Hartvigsen; Claus Manniche; Lars Korsholm; Niels Grunnet-Nilsson
Journal:  BMC Musculoskelet Disord       Date:  2006-10-25       Impact factor: 2.362

10.  The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients' Oncological Pathway.

Authors:  Sebastiano Mercadante; Claudio Adile; Amanda Caruselli; Patrizia Ferrera; Andrea Costanzi; Paolo Marchetti; Alessandra Casuccio
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

View more
  1 in total

1.  Personalized goal for insomnia and clinical response in advanced cancer patients.

Authors:  Sebastiano Mercadante; Claudio Adile; Federica Aielli; Lanzetta Gaetano; Kyriaki Mistakidou; Marco Maltoni; Andrea Cortegiani; Luiz Guilherme Soares; Stefano De Santis; Patrizia Ferrera; Marta Rosati; Romina Rossi; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2019-06-12       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.